Solid execution and cost disciplinePoised for next phase of Transformational JourneyThird Quarter 2024 Financial Highlights:Net Revenues of ...

Interim data from ongoing Phase 1 clinical trial of WTX-330, further characterizing tolerability and activity profile, to be presented at SITC ...

Q3 2024 Earnings Call Transcript November 7, 2024 4:30 AM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Hello. Greetings and welcome to the YPF Third Quarter 2024 Earnings Webcast Presentation. All participants are in a listen-only mode at this ...

During today’s presentation all parties will ... MANTIS opened doors with several high-profile customers, establishing our ...

Good morning, and welcome to the Axsome Therapeutics Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, there will be a question and ...

Research and development expenses increased to $17.0 million for the three months ended September 30, 2024 from $15.4 million for the three months ended September 30, 2023 primarily due to ...

Perfect for special occasions or as a thoughtful gift, Loubier's design ... family operated company, involves small batches ...

Pharmacokinetic Results: TX45 demonstrated a potential best-in-class half-life for a long-acting relaxin therapy. Final analysis showed that a single dose of TX45 had approximately 50% subcutaneous ...

AVerMedia's new affordable USB microphone, the VERSATI go, is a winner. The premium build quality and customization options match the sound quality.